OACC

Oaktree Acquisition Corp. III Life SciencesNASDAQFinancial Services

$10.56+0.00%ClosedMarket Cap: $259.6M

As of 2026-04-06

Valuation

P/E (TTM)

35.62

PEG

—

P/B

1.33

P/S

0.00

EV/EBITDA

284.36

DCF Value

—

FCF Yield

-0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.8%

ROA

3.6%

ROIC

-0.6%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	NaN%	$-255.5K	$1.8M	$0.07	—
FY 2025	$0.00	NaN%	$-1.2M	$7.3M	$0.30	—
Q3 2025	$0.00	NaN%	$-225.6K	$2.0M	$0.08	—
Q2 2025	$0.00	NaN%	$-269.8K	$1.9M	$0.08	—
Q1 2025	$0.00	NaN%	$-444.8K	$1.7M	$0.07	—
Q4 2024	$0.00	NaN%	$-303.7K	$1.4M	$0.06	—
FY 2024	$0.00	NaN%	$-703.00	$2.7K	$0.05	—
Q3 2024	$0.00	NaN%	$-48.1K	$-48.1K	$-0.00	—